We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Actuate Therapeutics is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). We are developing elraglusib (formerly 9-ING-41), a small molecule that is des... Actuate Therapeutics is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). We are developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B. We believe that the blockade of GSK-3B signaling ultimately results in the death of the cancer cells and the regulation of anti-tumor immunity. We have exclusively licensed a portfolio of GSK-3 inhibitors developed in a collaboration between the University of Illinois-Chicago (UIC) and Northwestern University (NU). Show more
Actuate Corporation (NASDAQ: ACTU) (NASDAQ: BIRT), The people behind BIRT® and the leading open source Business Intelligence vendor, today announced that it has recognized...
Actuate Corporation (NASDAQ:BIRT), The people behind BIRT® and the leading open source Business Intelligence vendor, today reported that BIRT has now been downloaded over 10...
Actuate Corporation (NASDAQ: ACTU)(NASDAQ: BIRT), the people behind BIRT® and the leading open source Business Intelligence vendor, today announced financial results for the...
Actuate Corporation (NASDAQ:ACTU), The people behind BIRT® and the leading open source Business Intelligence (BI) vendor, today announced that BIRT Mobile is available for...
Actuate Corporation (NASDAQ:ACTU), The people behind BIRT® and the leading open source Business Intelligence vendor, today announced the highlights of its upcoming Actuate...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.15 | -14.5202020202 | 7.92 | 10 | 6.75 | 118819 | 7.69590957 | CS |
4 | -2.22 | -24.6941045606 | 8.99 | 10 | 6.75 | 71975 | 8.21014411 | CS |
12 | 0.58 | 9.36995153473 | 6.19 | 10 | 6.19 | 56168 | 8.19555844 | CS |
26 | 1.77 | 35.4 | 5 | 10.162 | 5 | 36123 | 8.12191375 | CS |
52 | 1.77 | 35.4 | 5 | 10.162 | 5 | 18348 | 8.12191375 | CS |
156 | 1.77 | 35.4 | 5 | 10.162 | 5 | 6124 | 8.12191375 | CS |
260 | 1.77 | 35.4 | 5 | 10.162 | 5 | 4358 | 8.12191375 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions